New Two-Drug attack on advanced cancers enters Mid-Stage testing
NCT ID NCT07130383
Summary
This study is testing a combination of two new drugs, MHB036C and MHB039A, for people with advanced breast cancer or other advanced solid tumors that have spread. The main goals are to see if the drug combination is safe, how the body processes it, and if it can shrink or control tumors. It will enroll about 210 adults to find the right dose and get early signs of how well it works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
RECRUITINGShanghai, Shanghai Municipality, 201419, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.